Idorenyin Aiku
Family Medicine · Lawton, OKNPI 1740485614
Payments from drug & device makers
Across 133 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$331
- Lilly USA, LLC$293
- Pfizer$289
- AstraZeneca$274
- AbbVie$166
- Novo Nordisk$90
- plus $852 from 24 others
What the payments were for
- Food & beverage$2,295100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $331 |
| Lilly USA, LLC | 16 | $293 |
| Pfizer | 17 | $289 |
| AstraZeneca | 17 | $274 |
| AbbVie(2 entities) | 8 | $166 |
| Novo Nordisk | 5 | $90 |
| Sage Therapeutics, LLC | 4 | $76 |
| Amgen | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $64 |
| Medtronic | 2 | $62 |
| Merck | 4 | $56 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Boehringer Ingelheim | 3 | $47 |
| Astellas Pharma US Inc | 2 | $45 |
| Exact Sciences | 3 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Sobi, Inc | 2 | $33 |
| Organon | 2 | $32 |
| Tactile Systems Technology Inc | 2 | $31 |
| Mylan Specialty L.p. | 1 | $25 |
| Sanofi | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| Strongbridge US Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$2,295 in reported general payments places this provider in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $88,059 |
| JardianceEmpagliflozin | 50 | $83,061 |
| TrulicityDulaglutide | 47 | $69,047 |
| MounjaroTirzepatide | 33 | $50,268 |
| OzempicSemaglutide | 50 | $48,186 |
| LinzessLinaclotide | 17 | $23,225 |
| JanuviaSitagliptin Phosphate | 22 | $20,409 |
| ViberziEluxadoline | 12 | $18,220 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $10,542 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $9,504 |
| TegretolCarbamazepine | 13 | $9,432 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 413 | $8,170 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 151 | $7,667 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $6,981 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $6,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $293 | $119,31580 claims |
| PfizerEliquis, Premarin | $289 | $94,22395 claims |
| Boehringer IngelheimJardiance | $47 | $83,06150 claims |
| Novo NordiskOzempic | $90 | $48,18650 claims |
| AbbVieLinzess, Viberzi, Synthroid | $166 | $42,64741 claims |
| MerckJanuvia | $56 | $20,40922 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $49 | $9,50412 claims |
| AstraZenecaSymbicort | $274 | $6,42112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Lawton
- Carl GriffinOklahoma City$28.2M
- Lisa ConneryNorman$15.6M
- Kyle RicknerYukon$14.7M
- Robert LockwoodYukon$8.6M
- Steven CoxNorman$6.9M
- Alexander FrankOklahoma City$3.1M
- Rachel AndersonNorman$2.8M
- Robert WestcottLindsay$1.6M
- Charles LunnOklahoma City$1.4M
- Jeffrey ChasteenTulsa$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.